CEO of two public companies: one a biotech, Ergo Science, with a new drug for type 2 diabetes called Cycloset. Cycloset is now on the market with a superior cardiovascular profile. Also CEO of Lyris, Inc., a SF bay area provider of internet marketing technologies. Experienced executive in venture deals in biotech, healthcare and internet marketing. E-therapies such as SPARX require knowledge and experience in each of these areas.

Dr. Brendel taught at Harvard Medical School; was Chairman of the IRB at McLean Hospital, overseeing largest private psychiatric research institution in the US. Former editor of Harvard Review of Psychiatry, author of book Healing Psychiatry. Graduated from Yale, Harvard Medical School, and University of Chicago. Worked at Massachusetts General Hospital.

Eron has more than 10 years of experience in building and executing on internet marketing campaigns, including Google AdWords. Eron's experience includes using the Facebook, Twitter, and Linkedin online advertising platforms. He has several years of experience in recruiting patients with depression for psychiatrists.